Its grant season. The International Pemphigus and Pemphigoid Foundation (IPPF) is awarding 4-8 one-year grants in 2017 worth $25,000 - $50,000 to US-based researchers focused on pemphigus and pemphigoid.
The intent of these grants is to support well-defined research projects that have a specified benefit for improving the treatment, health, disease management, or diagnosis of persons with pemphigus and pemphigoid.
Rare Blistering Diseases
Pemphigus and pemphigoid are rare, autoimmune blistering disorders. If extensive, blistering can lead to life-threatening fluid loss, infection, and disfigurement. Pemphigus and pemphigoid can also cause significant damage to the skin, including nail loss and pigmentary alteration, making timeliness of intervention and treatment essential to prevention of disability.
For those interested, a letter of intent is due by February 28, 2017 and the application is due March 31, 217. Winners will be announced June 30, 2017 and funds made available by August 1, 2017.
The proposals will be reviewed by the IPPF’s Research Committee based on the peer review system used by the National Institutes of Health (NIH). Applications are individually scored by each member of the Research Committee, and scores are added together to determine the final ranking of each proposal.
Any reviewer with a conflict of interest is excused from voting on that specific proposal. The grant selection process is unbiased and independent; awards are based solely on scientific merit.
For more information, visit http://www.pemphigus.org/research/ippf-research-grant-program/